O'Donoghue D - Search Results

1

Mycophenolate mofetil for remission induction in severe lupus nephritis.

Cross J, Dwomoa A, Andrews P, Burns A, Gordon C, Main J, Mathieson P, O'Donoghue D, Jayne D; Renal Association Clinical Trials Subcommittee. Cross J, et al. Nephron Clin Pract. 2005;100(3):c92-100. doi: 10.1159/000085054. Epub 2005 Apr 11. Nephron Clin Pract. 2005. PMID: 15824513

2

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.

Howman A, Chapman TL, Langdon MM, Ferguson C, Adu D, Feehally J, Gaskin GJ, Jayne DR, O'Donoghue D, Boulton-Jones M, Mathieson PW. Howman A, et al. Lancet. 2013 Mar 2;381(9868):744-51. doi: 10.1016/S0140-6736(12)61566-9. Epub 2013 Jan 9. Lancet. 2013. PMID: 23312808 Free PMC article. Clinical Trial.

3

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D, Lockwood CM. Jayne DR, et al. QJM. 2000 Jul;93(7):433-9. doi: 10.1093/qjmed/93.7.433. QJM. 2000. PMID: 10874052 Clinical Trial.

4

Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study.

Chrysochou C, Randhawa H, Reeve R, Waldek S, Wood GN, O'Donoghue DJ, Kalra PA. Chrysochou C, et al. QJM. 2008 Apr;101(4):313-6. doi: 10.1093/qjmed/hcn008. Epub 2008 Feb 12. QJM. 2008. PMID: 18270227

5

Isolated sarcoid granulomatous interstitial nephritis: review of five cases at one center.

O'Riordan E, Willert RP, Reeve R, Kalra PA, O'Donoghue DJ, Foley RN, Waldek S. O'Riordan E, et al. Clin Nephrol. 2001 Apr;55(4):297-302. Clin Nephrol. 2001. PMID: 11334315

6

Effect of a Quality Improvement Program to Improve Guideline Adherence and Attainment of Clinical Standards in Dialysis Care: Report of Outcomes in Year 1.

Youssouf S, Nache A, Wijesekara C, Middleton RJ, Lewis D, Shurrab AE, O'Riordan E, Lappin LP, O'Donoghue D, Kalra PA, Hegarty J. Youssouf S, et al. Nephron. 2017;136(2):75-84. doi: 10.1159/000450890. Epub 2017 Feb 25. Nephron. 2017. PMID: 28237984

7

Factors associated with vascular stiffness: cross-sectional analysis from the Chronic Renal Insufficiency Standards Implementation Study.

Eddington H, Sinha S, Li E, Hegarty J, Ting J, Lane B, Chrysochou C, Foley R, O'Donoghue D, Kalra PA, Middleton R. Eddington H, et al. Nephron Clin Pract. 2009;112(3):c190-8. doi: 10.1159/000218108. Epub 2009 May 13. Nephron Clin Pract. 2009. PMID: 19439990

8

Cyclosporin A therapy in frequently relapsing nephrotic syndrome and IgA nephropathy.

Pritchard NR, Milford DV, O'Donoghue DJ. Pritchard NR, et al. Nephrol Dial Transplant. 1997 Nov;12(11):2402-4. doi: 10.1093/ndt/12.11.2402. Nephrol Dial Transplant. 1997. PMID: 9394331 No abstract available.

9

Functional status and mortality in chronic kidney disease: results from a prospective observational study.

Ritchie JP, Alderson H, Green D, Chiu D, Sinha S, Middleton R, O'Donoghue D, Kalra PA. Ritchie JP, et al. Nephron Clin Pract. 2014;128(1-2):22-8. doi: 10.1159/000362453. Epub 2014 Oct 29. Nephron Clin Pract. 2014. PMID: 25358837

10

Increasing frequency of adult IgA nephropathy in the UK?

Ballardie FW, O'Donoghue DJ, Feehally J. Ballardie FW, et al. Lancet. 1987 Nov 21;2(8569):1205. doi: 10.1016/s0140-6736(87)91336-5. Lancet. 1987. PMID: 2890823 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

512 results

Search Page

Filters